Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
39,194,600
-
Share change
-
+11,273,392
-
Total reported value
-
$82,317,219
-
Put/Call ratio
-
83%
-
Price per share
-
$2.10
-
Number of holders
-
74
-
Value change
-
+$23,221,707
-
Number of buys
-
42
-
Number of sells
-
29
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q3 2020
As of 30 Sep 2020,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,194,600 shares.
The largest 10 holders included
CAXTON CORP, NEA Management Company, LLC, ORBIMED ADVISORS LLC, Ikarian Capital, LLC, Stonepine Capital Management, LLC, BlackRock Inc., MORGAN STANLEY, VANGUARD GROUP INC, 683 Capital Management, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.